Drug Insights

Synapse Simplified: How to Find Ciprofloxacin Information

6 February 2024
2 min read

Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. It can be taken by mouth, as eye drops, as ear drops, or intravenously. It is a second-generation fluoroquinolone with a broad spectrum of activity that usually results in the death of the bacteria. Ciprofloxacin was patented in 1980 and introduced in 1987. It is on the World Health Organization's List of Essential Medicines. The World Health Organization classifies ciprofloxacin as critically important for human medicine. It is available as a generic medication.Common side effects include nausea, vomiting, and diarrhea. Severe side effects include an increased risk of tendon rupture, hallucinations, and nerve damage. Click on the image below to begin the exploration journey of Ciprofloxacin through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Alvotech Reveals Promising Preliminary Results for Potential Prolia® and Xgeva® Equivalent, AVT03
Latest Hotspot
2 min read
Alvotech Reveals Promising Preliminary Results for Potential Prolia® and Xgeva® Equivalent, AVT03
6 February 2024
Alvotech Reveals Encouraging Preliminary Findings from Drug Behavior Analysis of AVT03, a Potential Equivalent to Prolia® and Xgeva®.
Read →
A Complete Guide to Searching Diphenhydramine on Synapse
Drug Insights
2 min read
A Complete Guide to Searching Diphenhydramine on Synapse
6 February 2024
Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold.
Read →
FDA Approves Oricell's IND Application for Innovative CAR-T Therapy, OriCAR-017
Latest Hotspot
3 min read
FDA Approves Oricell's IND Application for Innovative CAR-T Therapy, OriCAR-017
6 February 2024
Oricell has received the green light from the FDA for its investigational new drug (IND) application for OriCAR-017, an innovative CAR-T therapy aimed at GPRC5D.
Read →
Using Synapse for Your Tamsulosin Research: An Easy Guide
Drug Insights
2 min read
Using Synapse for Your Tamsulosin Research: An Easy Guide
6 February 2024
Tamsulosin was approved for medical use in the United States in 1997. Specifically it is an α1 adrenergic receptor blocker.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.